Applied Therapeutics (APLT) Profit After Tax (2023 - 2025)
Historic Profit After Tax for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to -$19.0 million.
- Applied Therapeutics' Profit After Tax rose 7231.42% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.1 million, marking a year-over-year increase of 9031.66%. This contributed to the annual value of -$105.6 million for FY2024, which is 1180.58% up from last year.
- According to the latest figures from Q3 2025, Applied Therapeutics' Profit After Tax is -$19.0 million, which was up 7231.42% from -$21.3 million recorded in Q2 2025.
- In the past 5 years, Applied Therapeutics' Profit After Tax registered a high of $44.0 million during Q4 2024, and its lowest value of -$83.9 million during Q1 2024.
- Over the past 3 years, Applied Therapeutics' median Profit After Tax value was -$21.8 million (recorded in 2025), while the average stood at -$26.1 million.
- Per our database at Business Quant, Applied Therapeutics' Profit After Tax surged by 21679.45% in 2024 and then crashed by 83602.48% in 2025.
- Quarter analysis of 3 years shows Applied Therapeutics' Profit After Tax stood at -$37.7 million in 2023, then soared by 216.79% to $44.0 million in 2024, then tumbled by 143.15% to -$19.0 million in 2025.
- Its last three reported values are -$19.0 million in Q3 2025, -$21.3 million for Q2 2025, and -$21.8 million during Q1 2025.